Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 0.31 · gapped below the open, then crossed back over prior close. High/low 0.32 at 3:15 pm ET, 0.29 at 9:30 am ET.
TScan Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“To establish our proprietary position, we have filed provisional patent applications and corresponding Patent Cooperation Treaty (PCT), national, and regional applications related to our novel product candidates that are important to our business, and we have exclusively licensed a patent family from the Brigham and Women's Hospital, Inc. (BWH); we may in the future also license or purchase issued patents or pending patent applications filed by others.”
FILING10-K0001193125-26-089884cik 0001783328
“On December 20, 2024 (the SVB Loan Effective Date), we entered into a Loan and Security Agreement (SVB Loan Agreement) with Silicon Valley Bank, a division of First-Citizens Bank & Trust Company (SVB), pursuant to which, SVB will extend up to $52.5 million in a term loan facility, of which $32.5 million was fully funded at the SVB Loan Effective Date.”
FILING10-K0001193125-26-089884cik 0001783328
“On May 8, 2023, the Company entered into a Collaboration Agreement with Amgen Inc. (the Amgen Agreement) to identify antigens recognized by T cells in patients with Crohn's disease in accordance with a research plan.”
FILING10-K0001193125-26-089884cik 0001783328
“To date, our revenues have primarily consisted of consideration related to the Novartis Agreement and the Amgen Agreement, which we are accounting for under ASC 606.”
FILING10-K0001193125-26-089884cik 0001783328
“We are a party to technology licenses, including in-license agreements with BWH and PHSA, and we may enter into additional licenses in the future.”
FILING10-K0001193125-26-089884cik 0001783328
Watchlist prices, news filtered to it, and its next report on your desk.
TScan Therapeutics, Inc. has 3 disclosed suppliers and 2 disclosed customers. Each one is named in an SEC filing, either TScan Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
TCRX (TScan Therapeutics, Inc.) has 3 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: AMGN −1.33%, in healthcare.